Talking Medicines Launches AI-Powered Patient Intelligence Platform to Revolutionize Marketing for World s Leading Drug Brands
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210204005476/en/
Jo Halliday CEO Talking Medicines (Photo: Business Wire)
PatientMetRx uses AI to provide a systematic way of measuring patients experience of taking medicines.
Powered by EVA, a proprietary AI machine developed by Talking Medicines, PatientMetRx combines Machine Learning and Natural Language Processing to capture the voice of the patient from millions of conversations taking place over multiple sources including social media, forums and blogs, mapped to a curated database of 130,000 regulated global medicines. It distils what patients are saying online and more importantly, what they are feeling, into powerful data insights which are fully pharma compliant.